First and Second Generation ALK Inhibitors for the Treatment of Lung Cancer Published 2016-03-23 Download video MP4 360p Download video MP4 720p Recommendations 21:36 Strategies for Overcoming KRAS Mutations 05:32 Introduction to EGFR inhibitors 14:46 Excess Deaths at Night - Obstructive Sleep Apnea Explained Clearly 24:07 Sjogren's Syndrome Affects the Brain and Spine 10:49 Mary Lou Retton on Life Following Near-Death Mystery Illness: Why She Needed Fundraising (Exclusive) 54:01 Aspirin and cancer: the emerging evidence 17:40 What happens to lonely people under anesthesia? 18:40 Matthew Perry's death from Ketamine explained (is it safe for you?) 47:55 Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma 22:03 Stage IV Kidney Cancer The Road To Surgery - Part 2 32:32 The Era of ADCs in the Treatment of NSCLC 44:03 EGFR: The Challenge of Primary and Secondary Resistance 16:30 5 ways to overtake arrogant doctors - Dr. Kaveh LIVE 19:14 You have cancer... Part two 51:47 Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer 28:07 Understanding Lambert-Eaton Myasthenic Syndrome and Its Association with Small Cell Lung Cancer 03:00 How Monoclonal Antibodies Treat Cancer #cancer #monoclonalantibodies 36:13 SDHA Germline Genetic Testing and Surveillance in Clinical Practice 15:39 Understanding ADHD: Evolving Needs and Treatments 1:13:43 Highlights From Bruton’s Tyrosine Kinase Inhibitors Similar videos 02:20 Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance 07:11 Second-Generation ALK Inhibitors in Non-Small Cell Lung Cancer 30:32 2023 Best of Lung: Targeted Therapies in Lung Cancer 04:14 Should a Second Generation ALK Inhibitor be First Line Therapy for Patients with ALK-Positive NSCLC? 02:50 How do ALK-inhibitors work in ALK-positive lung cancer? 04:44 Are There Clinically Significant Differences Among the Second Generation ALK Inhibitors? 21:51 EML4/ALK and ROS-1: How do we sequence therapies 06:27 ALK Inhibitor Sequencing in NSCLC 42:31 ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw 01:01 Targeting ALK rearrangements in non-small cell lung cancer 02:26 Dr. Shaw on Alectinib as First-Line Therapy in Lung Cancer 04:58 Treating ALK+ mNSCLC With ALK Inhibitors 33:52 Keynote Lecture: Targeted Therapies in Lung Cancer 2.0 – Advances and Promises 05:53 Next-Generation ALK Inhibitors in Non-Small Cell Lung Cancer 06:14 Lorlatinib as First-Line Treatment for ALK-Positive Advanced Lung Cancer 02:00 Ceritinib and Other Second Generation ALK Inhibitors for Acquired Resistance in ALK-Positive NSCLC 37:23 NSCLC: Integrating EGFR-Inhibiting Therapies into Clinical Pathways for First-Line Treatment 03:44 ALK Inhibitors for Acquired Resistance: Zykadia and Alectinib 13:28 DEBATE: ALK positive NSCLC - Front line therapy - Crizotinib More results